Ratings watch: the risk of negative outlooks

Volatility arrows

The Greek sovereign debt crisis has raised questions about insurers’ investment portfolios and the ratings they attract because of this. Jakki May explains why brokers should be aware of the issue to provide the best service to their customers.

With the world watching and waiting to see if the Greek debt crisis can be successfully resolved without major impacting its neighbours in the Eurozone, questions have been asked about whether any

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: http://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Stark asbestos risk in UK schools brought into focus

Jonathan Edwards, head of insurance and risk at HCR Law, warns insurers and brokers they need to move from passive monitoring to proactive risk mitigation in order to prevent hundreds of thousands of teachers and pupils dying as a result of asbestos present in UK schools.

Broker Review of the Year 2024

Brokers were pleased with M&A activity in 2024 but ticked off by disproportionate regulation, capacity exiting the market and artificial intelligence failing to live up to expectations.

Insurance Post’s Christmas Special Podcast

Post content director Jonathan Swift, news editor Scott McGee and Emma Ann Hughes, editor, ditch the usual format of our publication’s award-winning podcast to deliver a holly, jolly Christmas Special.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here